Related Experiment Video
Updated: Feb 18, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
TMEM106a is a Novel Tumor Suppressor in Human Renal Cancer
Chenglong Wu1, Juan Xu2, Han Wang3
1Shenzhen Second People's Hospital, Guangzhou Medical University, Shenzhen, China.
Background/Aims:
In recent years the diagnosis and management of renal cancer has changed greatly, although the mechanism is still elusive. TMEM106a is a conserved type II transmembrane protein which is a key factor to regulate macrophage activation. Its inactivation in gastric cancer is frequently observed to be associated with poor prognosis. The role of TMEM106a in renal cancer remained unclear.
Methods:
TMEM106a expression profiling was performed in a panel of renal cancer cell lines and primary renal tissue cells. Then TMEM106a was overexpressed by a viral system in a renal cancer cell line with low level of TMEM106a. This stable cell line was assessed in multiple cell growth and migration assays. The results from TMEM106a overexpressing cell line were then confirmed with primary renal cells by siRNA knockdown of TMEM106a.
Results:
TMEM106a expression level was reduced in renal cancer cells compared to normal primary renal cells. Restoration of TMEM106a expression in TMEM106a-low renal cancer cells resulted in attenuated proliferation, reduced cell migration and enhanced caspase 3 dependent apoptosis compared to control cells. TMEM106a knockdown in primary renal cells led to increased colony formation compared to the control cells with scrambled siRNA transfection.
Conclusion:
TMEM106a is a novel tumor suppressor in renal cancer.
Insights
Transmembrane protein 106A (TMEM106a) acts as a tumor suppressor in renal cancer. Its reduced expression in kidney tumors correlates with increased proliferation and migration, highlighting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Renal cancer diagnosis and management are evolving, but underlying mechanisms remain unclear.
- Transmembrane protein 106A (TMEM106a) regulates macrophage activation and is linked to poor prognosis in gastric cancer.
- The specific role of TMEM106a in renal cancer was previously unknown.
Purpose of the Study:
- To investigate the expression and function of TMEM106a in renal cancer.
- To determine if TMEM106a acts as a tumor suppressor or oncogene in kidney cancer.
Main Methods:
- Analyzed TMEM106a expression in renal cancer cell lines and primary tissues.
- Overexpressed TMEM106a in a low-expression renal cancer cell line using viral vectors.
- Assessed cell proliferation, migration, and apoptosis following TMEM106a manipulation.
- Confirmed findings using siRNA knockdown in primary renal cells.
Main Results:
- TMEM106a expression was significantly lower in renal cancer cells than in normal renal cells.
- Restoring TMEM106a expression reduced proliferation and migration while enhancing apoptosis.
- TMEM106a knockdown in normal cells increased colony formation, suggesting a tumor-suppressive role.
Conclusions:
- TMEM106a functions as a novel tumor suppressor in renal cancer.
- TMEM106a's role in regulating cell growth and apoptosis suggests potential therapeutic applications.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Replicative Cell Senescence
Abnormal Proliferation

